| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038251664 |
| P356 | DOI | 10.1038/NBT813 |
| P698 | PubMed publication ID | 12679785 |
| P5875 | ResearchGate publication ID | 10818020 |
| P50 | author | Janet Rossant | Q6153583 |
| Tilo Kunath | Q42089804 | ||
| P2093 | author name string | Heiko Lickert | |
| Tony Pawson | |||
| Nina Jones | |||
| Gerald Gish | |||
| P2860 | cites work | Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 |
| A system for stable expression of short interfering RNAs in mammalian cells | Q27860875 | ||
| Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells | Q27860926 | ||
| RNA interference | Q28131798 | ||
| Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein | Q28584833 | ||
| Derivation of completely cell culture-derived mice from early-passage embryonic stem cells | Q29547491 | ||
| A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference | Q29615920 | ||
| Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems | Q33933613 | ||
| A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. | Q34762243 | ||
| An unusually compact external promoter for RNA polymerase III transcription of the human H1RNA gene | Q39094983 | ||
| Small interfering RNA and gene silencing in transgenic mice and rats | Q40686310 | ||
| Effective expression of small interfering RNA in human cells | Q40735246 | ||
| Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells | Q40735249 | ||
| Generating green fluorescent mice by germline transmission of green fluorescent ES cells | Q42819708 | ||
| Germline transmission of RNAi in mice | Q44283786 | ||
| An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo | Q60614674 | ||
| P433 | issue | 5 | |
| P921 | main subject | phenotype | Q104053 |
| RNA interference | Q201993 | ||
| embryonic stem cell | Q1151519 | ||
| P304 | page(s) | 559-561 | |
| P577 | publication date | 2003-04-07 | |
| P1433 | published in | Nature Biotechnology | Q1893837 |
| P1476 | title | Transgenic RNA interference in ES cell-derived embryos recapitulates a genetic null phenotype. | |
| P478 | volume | 21 |
| Q33374438 | A construct with fluorescent indicators for conditional expression of miRNA. |
| Q24809319 | A rapid and sensitive assay for quantification of siRNA efficiency and specificity |
| Q40671931 | AAV9 Delivery of shRNA to the Mouse Heart. |
| Q33914682 | Accelerating cancer modeling with RNAi and nongermline genetically engineered mouse models |
| Q24306311 | Adaptor protein Nck1 interacts with p120 Ras GTPase-activating protein and regulates its activity |
| Q34033898 | Aggregation chimeras: combining ES cells, diploid, and tetraploid embryos |
| Q35050602 | An RNAi-based approach to down-regulate a gene family in vivo |
| Q28594877 | An inducible RNA interference system for the functional dissection of mouse embryogenesis |
| Q28507045 | Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinase |
| Q37024552 | Analysis of behavior using genetical genomics in mice as a model: from alcohol preferences to gene expression differences |
| Q33436063 | Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy |
| Q28593688 | Baf60c is essential for function of BAF chromatin remodelling complexes in heart development |
| Q39900080 | Betanodavirus non-structural protein B2: A novel necrotic death factor that induces mitochondria-mediated cell death in fish cells |
| Q36404147 | Building mammalian signalling pathways with RNAi screens |
| Q33854159 | C --> T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases |
| Q38105594 | Capillary malformation--arteriovenous malformation syndrome: review of the literature, proposed diagnostic criteria, and recommendations for management |
| Q40106323 | Caveolin 1 restricts Group A Streptococcus invasion of nonphagocytic host cells |
| Q37779599 | Conditional RNAi in mice. |
| Q35891582 | Conditional brain-specific knockdown of MAPK using Cre/loxP regulated RNA interference |
| Q34756517 | Conditional transgenic mouse models: from the basics to genome-wide sets of knockouts and current studies of tissue regeneration. |
| Q51892678 | Constitutive and conditional RNAi transgenesis in mice. |
| Q36846842 | Contemporary approaches for modifying the mouse genome |
| Q24564248 | Cre-lox-regulated conditional RNA interference from transgenes |
| Q36299352 | Current issues in mouse genome engineering |
| Q35894395 | Deciphering the renal code: advances in conditional gene targeting |
| Q37737316 | Delivery of RNA interference triggers to sensory neurons in vivo using herpes simplex virus |
| Q35721451 | Developmental and adult phenotyping directly from mutant embryonic stem cells |
| Q27320201 | Dickkopf homolog 3 (DKK3) plays a crucial role upstream of WNT/β-CATENIN signaling for Sertoli cell mediated regulation of spermatogenesis |
| Q35855618 | Differentiation and diversification of vascular cells from embryonic stem cells |
| Q33770336 | Efficiency of RNA interference in the mouse hematopoietic system varies between cell types and developmental stages |
| Q34094960 | Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. |
| Q58829853 | Functional analysis of the SRY-KRAB interaction in mouse sex determination |
| Q40593623 | Functional silencing of hepatic microsomal glucose-6-phosphatase gene expression in vivo by adenovirus-mediated delivery of short hairpin RNA. |
| Q25255923 | Functional studies of signaling pathways in peri-implantation development of the mouse embryo by RNAi |
| Q39669007 | Gene knockdown in the mouse through RNAi. |
| Q35498674 | Gene regulatory networks in embryonic stem cells and brain development |
| Q40318702 | Gene silencing in Xenopus laevis by DNA vector-based RNA interference and transgenesis |
| Q54763136 | Gene silencing in mammalian cells by PCR-based short hairpin RNA. |
| Q35855469 | Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. |
| Q34983927 | Heritable and stable gene knockdown in rats |
| Q42147320 | High-efficiency Rosa26 knock-in vector construction for Cre-regulated overexpression and RNAi |
| Q33220982 | How will RNAi facilitate drug development? |
| Q35773259 | Improving the efficiency of RNA interference in mammals |
| Q42941339 | In vivo analysis of gene knockdown in tetracycline-inducible shRNA mice. |
| Q46003290 | Inactivation of Ras by p120GAP via focal adhesion kinase dephosphorylation mediates RGMa-induced growth cone collapse. |
| Q35131494 | Inducible suppression of Fgfr2 and Survivin in ES cells using a combination of the RNA interference (RNAi) and the Cre-LoxP system. |
| Q45474715 | Inhibition of hepatitis B virus replication in 2.2.15 cells by expressed shRNA. |
| Q38756728 | Investigation of the role of TASK-2 channels in rat pulmonary arteries; pharmacological and functional studies following RNA interference procedures. |
| Q40492195 | Knockdown of mouse adult beta-globin gene expression in MEL cells by retrovirus vector-mediated RNA interference |
| Q45874854 | Knocking down human disease: potential uses of RNA interference in research and gene therapy |
| Q37791489 | Lentiviral Vector-Mediated Gene Transfer and RNA Silencing Technology in Neuronal Dysfunctions |
| Q36364923 | Lentiviral vectors for use in the central nervous system. |
| Q37567860 | Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells |
| Q40062659 | Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types |
| Q24613766 | MicroRNA-mediated regulation of the angiogenic switch |
| Q39528390 | MicroRNA122 is a key regulator of α-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma. |
| Q37799368 | Mouse Models of Cancer |
| Q34277450 | Mouse embryonic chimeras: tools for studying mammalian development |
| Q35107829 | Multiple renal cyst development but not situs abnormalities in transgenic RNAi mice against Inv::GFP rescue gene |
| Q52000320 | Murine embryonic stem cells. |
| Q36903592 | New technology for an old favorite: lentiviral transgenesis and RNAi in rats |
| Q53374678 | New tools for functional mammalian cancer genetics |
| Q28504826 | Nuclear mRNA degradation pathway(s) are implicated in Xist regulation and X chromosome inactivation |
| Q28506343 | Nucleolar release of Hand1 acts as a molecular switch to determine cell fate |
| Q28588217 | Oct4 RNA interference induces trophectoderm differentiation in mouse embryonic stem cells |
| Q33193599 | Oligonucleotide‐Based Knockdown Technologies: Antisense Versus RNA Interference |
| Q35728858 | Optimizing RNA interference for application in mammalian cells |
| Q30009346 | Phosphorylation of Dok1 by Abl family kinases inhibits CrkI transforming activity |
| Q21145272 | Pol II-expressed shRNA knocks down Sod2 gene expression and causes phenotypes of the gene knockout in mice |
| Q28591889 | Polycomb-like 2 associates with PRC2 and regulates transcriptional networks during mouse embryonic stem cell self-renewal and differentiation |
| Q36565686 | Promises and challenges in developing RNAi as a research tool and therapy for neurodegenerative diseases |
| Q45883640 | Quorum-sensing-based toolbox for regulatable transgene and siRNA expression in mammalian cells |
| Q60609674 | RNA Interference in Pigs: Comparison of RNAi Test Systems and Expression Vectors |
| Q52100105 | RNA inhibition of BMP‐4 gene expression in postimplantation mouse embryos |
| Q40484644 | RNA interference against a glioma-derived allele of EGFR induces blockade at G2M. |
| Q36415321 | RNA interference in embryonic stem cells and the prospects for future therapies |
| Q58493817 | RNA interference in postimplantation mouse embryos |
| Q33215530 | RNA interference: from gene silencing to gene-specific therapeutics |
| Q42831128 | RNA interfering approach for clarifying the PPARgamma pathway using lentiviral vector expressing short hairpin RNA. |
| Q36631553 | RNA-mediated gene silencing in hematopoietic cells |
| Q45723356 | RNAi puts a lid on virus replication |
| Q36597924 | RNAi therapy for neurodegenerative diseases. |
| Q35633404 | RNAi-based conditional gene knockdown in mice using a U6 promoter driven vector |
| Q54377682 | RNAi-mediated knockdown of IKK1 in transgenic mice using a transgenic construct containing the human H1 promoter. |
| Q36836615 | RNAi-mediated knockdown of target genes: a promising strategy for pancreatic cancer research |
| Q37700966 | RUSH and CRUSH: a rapid and conditional RNA interference method in mice |
| Q28580317 | Ras GTPase-activating protein binds to Akt and is required for its activation |
| Q38029545 | Recent advances in the development of new transgenic animal technology |
| Q40283426 | Reproducible and inducible knockdown of gene expression in mice |
| Q24676820 | Self-renewal of embryonic stem cells by a small molecule |
| Q40433218 | Short hairpin RNA targeted to the highly conserved 2B nonstructural protein coding region inhibits replication of multiple serotypes of foot-and-mouth disease virus |
| Q45834761 | Simultaneous Cre-mediated conditional knockdown of two genes in mice |
| Q24797255 | Single copy shRNA configuration for ubiquitous gene knockdown in mice |
| Q40480264 | Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy. |
| Q36299354 | Strategies for dissecting epigenetic mechanisms in the mouse |
| Q30448321 | Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function |
| Q36342446 | Targeted microRNA expression in dairy cattle directs production of β-lactoglobulin-free, high-casein milk |
| Q33863444 | The Rho GTP exchange factor Lfc promotes spindle assembly in early mitosis |
| Q40169132 | The Shb signalling scaffold binds to and regulates constitutive signals from the Epstein-Barr virus LMP2A membrane protein |
| Q24794985 | The functional landscape of mouse gene expression |
| Q22122054 | The knockout mouse project |
| Q64111109 | The platelet-derived growth factor receptor alpha promoter-directed expression of cre recombinase in mouse placenta |
| Q42504195 | Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. |
| Q80093210 | Tissue-specific and cell type-specific RNA interference in vivo |
| Q24793831 | Towards in vivo application of RNA interference - new toys, old problems |
| Q45864350 | Transgene expression and RNA interference in embryonic stem cells |
| Q36844414 | Transgenic RNA interference in mice |
| Q84713069 | Transgenic RNAi applications in the mouse |
| Q36508882 | Transgenic RNAi: Accelerating and expanding reverse genetics in mammals |
| Q36295015 | Transgenic modifications of the rat genome |
| Q35220727 | Transplacental RNAi: deciphering gene function in the postimplantation-staged embryo |
| Q34348958 | Unlocking the potential of the human genome with RNA interference |
| Q36864047 | Utilizing RNA interference to enhance cancer drug discovery |
| Q35581903 | Vector Systems for the Delivery of Small Interfering RNAs: Managing the RISC |
| Q28594679 | Zfp206 regulates ES cell gene expression and differentiation |
| Q31148783 | p120RasGAP is a mediator of rho pathway activation and tumorigenicity in the DLD1 colorectal cancer cell line |
Search more.